APA (7th ed.) Citation

S, C., R, Z., Y, Z., RD, C., Y, Z., S, R., & L, J. (2022). Effect of dipeptidyl peptidase-4 inhibitors on postprandial glucagon level in patients with type 2 diabetes mellitus: A systemic review and meta-analysis. Frontiers in endocrinology, 13, 994944. https://doi.org/10.3389/fendo.2022.994944

Chicago Style (17th ed.) Citation

S, Chai, Zhang R, Zhang Y, Carr RD, Zheng Y, Rajpathak S, and Ji L. "Effect of Dipeptidyl Peptidase-4 Inhibitors on Postprandial Glucagon Level in Patients with Type 2 Diabetes Mellitus: A Systemic Review and Meta-analysis." Frontiers in Endocrinology 13 (2022): 994944. https://doi.org/10.3389/fendo.2022.994944.

MLA (9th ed.) Citation

S, Chai, et al. "Effect of Dipeptidyl Peptidase-4 Inhibitors on Postprandial Glucagon Level in Patients with Type 2 Diabetes Mellitus: A Systemic Review and Meta-analysis." Frontiers in Endocrinology, vol. 13, 2022, p. 994944, https://doi.org/10.3389/fendo.2022.994944.